ACSBG2 and neoplasm: Eight downregulated lncRNAs—lnc-ACSBG2-1:1; lnc-ANKRD54-1:1; lnc-BOD1-1:7, -1:8, and -1:9; and lnc-MUC22-1:1, -1:7, and -1:8—demonstrated correlation between lower patient survival rate with lower expression of lncRNA, indicating a potential tumor-suppressing role for these lncRNAs.